<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no" /> <meta http-equiv="X-UA-Compatible" content="IE=9; IE=8; IE=7; IE=EDGE" /> <link rel="stylesheet" href="https://use.typekit.net/dbz4rwe.css" /> <style> body { margin: 0; padding: 0; } table { width: initial; } table td, table th { padding: 0; } h6, h5, h4, h3, h2, h1, p { margin: 0; } /*RESPONSIVE MOBILE*/ @media only screen and (max-width: 600px) { .container_general, .container_header, .container_main, .container_footer { width: 100% !important; } .deviceWidth { width: 100% !important; } .inline_img { text-align: center; display: block; width: 100% !important; height: auto !important; } .inline { text-align: center; display: block; width: 100% !important; padding: 5px 0; } .inline_article { display: inline-block; width: 100% !important; padding: 0px !important; } .flexibleImage { width: 100%; } .sousbutton { width: 100% !important; } .button { width: 100% !important; } .mensuel { text-align: center !important; } .logo_reseau1 { width: 14px; } .logo_reseau2 { width: 30px; } .logo_reseau3 { width: 27px; } } @media only screen and (max-width: 300px) { .inline_pub { width: 100% !important; } } </style> </head> <body bgcolor="#cecece" style="width: 100%; background-color: #cecece;"> <table cellspacing="0" cellpadding="0" bgcolor="#F5F6F8" align="center" class="container_general" width="600" style="table-layout: fixed;max-width:600px; width:600px;"> <tr> <td> <!-- HEADER --> <table stycellspacing="0" cellpadding="0" border="0" style="width: 100%;"> <tr> <td height="10" colspan="3"></td> </tr> </table> <table stycellspacing="0" cellpadding="0" border="0" bgcolor="#FFFFFF" align="center" width="95%" style="width: 95%; border-radius: 5px;"> <tr> <td height="5" colspan="3"></td> </tr> <tr> <td align="center" width="100%"> <a href="https://www.egora.fr" target="_blank"><img src="https://tracker.egora.fr/custloads/278893944/md_2670587.png" width="30%" style="max-width:150px; display:block; font-family: sans-serif; display: block;" class="logo_CP" /></a> </td> </tr> <tr> <td align="center" width="100%"> <p style="font-family: Trebuchet MS; margin: 0;font-size: 20px;color: #1D1D1B;font-weight: 600;line-height: 22px; text-transform: uppercase;"> En bref <span style="color: #DC344F;font-size: 30px;">•</span> </p> <p style="font-family: Arial; margin: 0;font-size: 12px;color: #707070;font-weight: lighter;"> <!-- La Date --> 12/05/2025 </p> </td> </tr> <tr> <td height="5" colspan="3"></td> </tr> </table> <table stycellspacing="0" cellpadding="0" border="0" style="width: 100%;"> <tr> <td height="10" colspan="3"></td> </tr> </table> <!-- MAIN --> <table cellspacing="0" cellpadding="0" border="0" bgcolor="#FFFFFF" align="center" class="container_header" width="600"> <div class="field field--name-field-bloc-newsletter field--type-entity-reference-revisions field--label-hidden field__items"> <div class="field__item"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/societe/80-des-medecins-generalistes-favorables-une-legalisation-de-laide-mourir?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;"> <table stycellspacing="0" cellpadding="0" bgcolor="#F5F6F8" class="inline_article" border="0" align="center" width="95%" style="width: 95%; border-radius: 5px;"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center" width="50%" style="padding: 0px 0px 0px 0px;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/societe/80-des-medecins-generalistes-favorables-une-legalisation-de-laide-mourir?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank"><img src="https://www.egora.fr/sites/default/files/styles/newsletter_a_la_une/public/2025-04/fin%20de%20vie%20soins%20palliatifs%20hopital.jpg?itok=Xjf4gqEV" width="100%" style="max-width:600; display:block; font-family: sans-serif; display: block; border-radius: 10px;" class="logo_CP" /></a> </td> <td class="inline_article" align="center" valign="top"> <table cellspacing="0" cellpadding="0" border="0" width="90%" style="width: 90%;" align="center"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; color:#DC344F; margin: 0;font-size: 11px;font-weight: 600;line-height: 24px; font-family:Arial;text-transform: uppercase;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/societe/80-des-medecins-generalistes-favorables-une-legalisation-de-laide-mourir?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#DC344F; margin: 0;font-size: 11px;font-weight: 600;line-height: 24px; font-family:Arial;text-transform: uppercase;">Société</a> </p> <p style="text-decoration: none; color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/societe/80-des-medecins-generalistes-favorables-une-legalisation-de-laide-mourir?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> 80% des médecins généralistes favorables à une légalisation de l'aide à mourir </a> </p> </td> </tr> </table> </td> <td width="20"></td> </tr> <tr> <td height="10" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center" colspan="2"> <table cellspacing="0" cellpadding="0" border="0" width="100%" align="left"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; color:#6E6E6D; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/societe/80-des-medecins-generalistes-favorables-une-legalisation-de-laide-mourir?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#6E6E6D; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> Un sondage Ifop paru dimanche 11 mai en exclusivité dans La Tribune dimanche relève que 74% des médecins français souhaitent la légalisation de l'aide active à mourir pour les patients, qui la demandent "expressément et de manière réitérée". </a> </p> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/societe/80-des-medecins-generalistes-favorables-une-legalisation-de-laide-mourir?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="color:#DC344F; margin: 0;font-size: 12px !important;font-weight: bold;line-height: 24px; font-family:Arial; text-transform: uppercase; text-decoration: underline !important;">LIRE [...]</a> </td> </tr> </table> </td> <td width="20"></td> </tr> <tr> <td height="20" colspan="3"></td> </tr> </table> </a> </td> </tr> </div> <div class="field__item"> <!-- Placement de l'image --> <!-- Couleur de fond --> <!-- TU CONSTRUIS TON TABLE AVEC LES VALEUR CI-DESSOUS --> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/judiciaire/proces-le-scouarnec-les-experts-psychiatres-livrent-leur-analyse?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;"> <table stycellspacing="0" cellpadding="0" bgcolor="#7E7C7B" class="inline_article" border="0" align="center" width="95%" style="width:95%; border-radius: 5px;"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center"> <table cellspacing="0" cellpadding="0" border="0" width="90%" style="width:90%" align="left"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; color:#FFFFFF; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/judiciaire/proces-le-scouarnec-les-experts-psychiatres-livrent-leur-analyse?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#FFFFFF; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> Procès Le Scouarnec : les experts psychiatres livrent leur analyse </a> </p> </td> </tr> </table> </td> <td class="inline_article" align="center" width="22%" style="width:22%; padding: 0px 0px 0px 0px;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/judiciaire/proces-le-scouarnec-les-experts-psychiatres-livrent-leur-analyse?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank"><img src="https://www.egora.fr/sites/default/files/styles/newsletter_article_avec_image/public/2025-05/AdobeStock_33754931-justice-tribunal.jpeg?itok=rd-XdYKe" width="100%" style="width:100%; max-width:600; display:block; font-family: sans-serif; display: block;" class="logo_CP" /></a> </td> <td width="20"></td> </tr> <tr> <td height="10" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center" colspan="2"> <table cellspacing="0" cellpadding="0" border="0" width="100%" align="left"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; color:#FFFFFF; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/judiciaire/proces-le-scouarnec-les-experts-psychiatres-livrent-leur-analyse?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#FFFFFF; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> L'ex-chirurgien Joël Le Scouarnec, jugé depuis le 24 février à Vannes pour des viols et agressions sur 299 patients, était "totalement responsable de ses actes", ont déclaré lundi 12 mai les deux experts psychiatres. </a> </p> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/judiciaire/proces-le-scouarnec-les-experts-psychiatres-livrent-leur-analyse?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="color:#FFFFFF; margin: 0;font-size: 12px !important;font-weight: bold;line-height: 24px; font-family:Arial; text-decoration: underline !important;">LIRE [...]</a> </td> </tr> </table> </td> <td width="20"></td> </tr> <tr> <td height="20" colspan="3"></td> </tr> </table> </a> </td> </tr> </div> <div class="field__item"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td width="100%" bgcolor="#FFF" style="vertical-align: top; background-color:#FFF;"> <table stycellspacing="0" cellpadding="0" class="inline_pub" width="305" height="250" style="width:305px; height:250px; background-color:#FFF;" class="inline_article" border="0" align="center"--> <!--table stycellspacing="0" cellpadding="0" class="inline_pub" width="100%" style="background-color:#FFF;" class="inline_article" border="0" align="center" --> <tr> <td width="100%" style="vertical-align: top;"> <a href="https://espace.egora.fr/sucres-et-alimentation/accueil?y=7ypldF22" target="_blank"><img src="https://www.egora.fr/sites/default/files/newsletter/pub/2025-05/PV%20-%20Sucres%20%26%20alimantation%20-%20Culture%20Sucre%20%282%29_1.png" width="300" height="250" style="width:300px; height:250px; display:block; font-family: sans-serif; display: block;" class="logo_CP" /></a> </td> </tr> </table> <!-- PIXEL DE COMPTAGE --> <table width="100%" bgcolor="#ffffff" class="content deviceWidth" align="center" cellpadding="0" cellspacing="0" border="0"> <tr> <td> </td> </tr> </table> </td> </tr> </div> <div class="field__item"> <!-- Placement de l'image --> <!-- Couleur de fond --> <!-- Quand il n'y a pas de code couleur --> <!-- TU CONSTRUIS TON TABLE AVEC LES VALEUR CI-DESSOUS --> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/actus-medicales/vaccins-anti-grippaux-la-has-recommande-de-privilegier-efluelda-et-fluad?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;"> <table stycellspacing="0" cellpadding="0" bgcolor="#F5F6F8" class="inline_article" border="0" align="center" width="95%" style="width:95%; border-radius: 5px;"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center" width="22%" style="width:22%; padding: 0px 0px 0px 0px;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/actus-medicales/vaccins-anti-grippaux-la-has-recommande-de-privilegier-efluelda-et-fluad?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank"><img src="https://www.egora.fr/sites/default/files/styles/newsletter_article_avec_image/public/2025-05/AdobeStock_317801793.jpeg?itok=a9IymfYc" width="100%" style="width:100%; max-width:600; display:block; font-family: sans-serif; display: block;" class="logo_CP" /></a> </td> <td class="inline_article" align="center"> <table cellspacing="0" cellpadding="0" border="0" width="90%" style="width:90%" align="center"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/actus-medicales/vaccins-anti-grippaux-la-has-recommande-de-privilegier-efluelda-et-fluad?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> Vaccins anti-grippaux : la HAS recommande de privilégier Efluelda et Fluad chez les sujets âgés </a> </p> </td> </tr> </table> </td> <td width="20"></td> </tr> <tr> <td height="10" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center" colspan="2"> <table cellspacing="0" cellpadding="0" border="0" width="100%" align="left"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; color:#6E6E6D; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/actus-medicales/vaccins-anti-grippaux-la-has-recommande-de-privilegier-efluelda-et-fluad?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#6E6E6D; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> La Haute Autorité de santé a décidé de repositionner les vaccins anti-grippaux fortement dosés, Efluelda de Sanofi et Fluad de Vifor France, dans la stratégie de lutte contre cette infection saisonnière. </a> </p> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/actus-medicales/vaccins-anti-grippaux-la-has-recommande-de-privilegier-efluelda-et-fluad?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="color:#DC344F; margin: 0;font-size: 12px !important;font-weight: bold;line-height: 24px; font-family:Arial; text-decoration: underline !important;">LIRE [...]</a> </td> </tr> </table> </td> <td width="20"></td> </tr> <tr> <td height="20" colspan="3"></td> </tr> </table> </a> </td> </tr> </div> <div class="field__item"> <!-- Couleur de fond --> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/societe/aide-mourir-aucun-soignant-ne-sera-oblige-de-pratiquer-lacte-letal-promet-vautrin?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;"> <table stycellspacing="0" cellpadding="0" bgcolor="#DC344F" class="inline_article" border="0" align="center" width="95%" style="width:95%; border-radius: 5px;"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center"> <table cellspacing="0" cellpadding="0" border="0" width="100%" style="width:100%;" align="center"> <tr> <td class="inline" align="left"> <p style="text-decoration: none;color:#FFFFFF; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/societe/aide-mourir-aucun-soignant-ne-sera-oblige-de-pratiquer-lacte-letal-promet-vautrin?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;color:#FFFFFF; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> Aide à mourir : "Aucun soignant ne sera obligé de pratiquer l'acte létal", promet Vautrin </a> </p> <br /> <p style="text-decoration: none; color:#FFFFFF; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/societe/aide-mourir-aucun-soignant-ne-sera-oblige-de-pratiquer-lacte-letal-promet-vautrin?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#FFFFFF; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> Alors que les députés doivent commencer à examiner en séance publique les deux textes relatifs à la fin de vie ce lundi 12 mai, la ministre du Travail et de la Santé a défendu la possibilité d'ouvrir une aide à mourir, tout en soutenant un… </a> </p> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/actus-pro/societe/aide-mourir-aucun-soignant-ne-sera-oblige-de-pratiquer-lacte-letal-promet-vautrin?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="color:#FFFFFF; margin: 0;font-size: 12px !important;font-weight: bold;line-height: 24px; font-family:Arial; text-decoration: underline !important;">LIRE L'ARTICLE</a> </td> </tr> </table> </td> <td width="20"></td> </tr> <tr> <td height="20" colspan="3"></td> </tr> </table> </a> </td> </tr> </div> <div class="field__item"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td> <table width="95%" id="logoraRoot" class="logoraContainer" style="width:95%;border-collapse:initial;border-radius:5px;" bgcolor="#F5F6F8" align="center" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="40%"> <table width="58%" style="border-collapse:initial;" align="left" border="0" cellpadding="0" cellspacing="0"> <tr><td height="0"></td></tr> <tr> <td style="mso-line-height-rule: exactly;display:inline-block;border-left:solid 20px #DC344F;border-radius:6px 0 6px 0;border-right:solid 20px #DC344F;color:#fff; background-color:#DC344F;font-family:'Montserrat', sans-serif;"> <a style="font-size: 13px;text-decoration:none !important; text-transform: uppercase;text-decoration:none;font-family:'Montserrat', sans-serif;color:#fff;font-weight:600;line-height:32px;" data-url="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path" href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path?" target="_top">Débat des lecteurs</a> </td> </tr> <tr><td height="15"></td></tr> <tr> <td style="mso-line-height-rule: exactly; border-radius: 0 6px 0 6px;font-size: 16px;display:inline-block;border-left:solid 20px #F5F6F8;color:#1D1D1B; background-color:#F5F6F8;font-family:'Montserrat', sans-serif;"> <a style="font-size: 16px;text-decoration:none !important; text-transform: uppercase;text-decoration:none;font-family:'arial';color:#1D1D1B;font-weight:600" data-url="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path" href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path?" target="_top">Donnez</a> <a style="font-size: 16px;text-decoration:none !important; text-transform: uppercase;text-decoration:none;font-family:'arial';color:#DC344F;font-weight:600" data-url="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path" href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path?" target="_top"> Votre avis</a> </td> </tr> <tr><td height="6"></td></tr> </table> </td> <td width="60%" bgcolor="#F5F6F8"></td> </tr> <tr><td height="5"></td></tr> <tr> <td align="center" style="border-left:solid 20px #F5F6F8;border-right:solid 20px #F5F6F8;" width="100%"> <table width="100%" style="border-collapse:initial;" bgcolor="#F5F6F8" align="center" border="0" cellpadding="0" cellspacing="0"> <!--Titre débat--> <tr> <td colspan="2"> <a style="text-decoration:none !important; mso-line-height-rule: exactly; text-decoration:none;line-height:1.2;font-size: 16px;color:#1D1D1B;font-weight:600;font-family:Arial;" data-url="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path" href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path?" target="_top">Après l'angine et la cystite, faut-il autoriser les pharmaciens à prendre en charge davantage de pathologies "simples"?</a> </td> </tr> <tr><td height="15"></td></tr> <tr> <td border="0" width="40%"> <table width="100%" align="left" bgcolor="#F5F6F8" cellpadding="0" cellspacing="0"> <!-- réponse 1--> <tr> <td width="100%"> <table width="95%" align="left" bgcolor="#008575" style="width:95%;border-radius:6px" cellpadding="0" cellspacing="0"> <tr><td height="8"></td></tr> <tr> <td style="border-left:solid 10px #008575;"> <a data-url="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path" href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path?" target="_blank" style="width:100%;display: block;text-decoration:none !important;text-align:left;margin:0;display:inline-block;mso-line-height-rule: exactly;font-size: 17px;color:#fff;background-color:#008575;font-weight:bold;font-family:'Montserrat', sans-serif;"> Oui </a> </td> </tr> <tr><td height="8"></td></tr> </table> </td> <td width="30%"></td> </tr> <tr><td height="5"></td></tr> <!-- réponse 2--> <tr> <td width="100%"> <table width="95%" align="left" bgcolor="#DC344F" style="width:95%; border-radius:6px" cellpadding="0" cellspacing="0"> <tr><td height="8"></td></tr> <tr> <td style="border-left:solid 10px #DC344F;"> <a data-url="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path" href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path?" target="_blank" style="width:100%;display: block;text-decoration:none !important;text-align:left;margin:0;display:inline-block;mso-line-height-rule: exactly;font-size: 17px;color:#fff;background-color:#DC344F;font-weight:bold;font-family:'Montserrat', sans-serif;"> Non </a> </td> </tr> <tr><td height="8"></td></tr> </table> </td> <td width="30%"></td> </tr> <tr><td height="5"></td></tr> <!-- réponse 3 "Sans opinion"--> <tr> <td width="100%"> <table width="95%" align="left" bgcolor="#fff" style="width:95%;border:solid 3px #9b9b9b; border-radius:6px" cellpadding="0" cellspacing="0"> <tr><td height="8"></td></tr> <tr> <td style="border-left:solid 8px #fff"> <a data-url="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path" href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path?" target="_blank" style="width:100%;display: block;text-decoration:none !important;text-align:left;margin:0;display:inline-block;mso-line-height-rule: exactly;font-size: 17px;color:#9b9b9b;background-color:#fff;font-weight:bold;font-family:'Montserrat', sans-serif;"> Sans opinion </a> </td> </tr> <tr><td height="8"></td></tr> </table> </td> <td width="30%"></td> </tr> <tr><td height="15"></td></tr> <!-- Nombre de votes--> <tr> <td colspan="2"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path?initVote=true" style="font-weight:600;text-transform:uppercase;margin:0;font-size:12px;color:#DC344F;text-decoration: underline !important;font-family:'Montserrat', sans-serif;">478 votes - Voir le résultat</a> </td> </tr> </table> </td> <!--Argument--> <td width="70%" border="0" align="left"> <table width="98%" align="left" bgcolor="#fff" cellpadding="0" cellspacing="0"> <tr><td height="10"></td></tr> <tr> <td width="10"></td> <!--profil--> <td align="left"> <table width="98%" align="left" border="0" bgcolor="#fff" cellpadding="0" cellspacing="0"> <tr> <!--photo profil--> <td width="26" align="left"> <img class="GkKPC" src="https://storage.logora.com/uploads/standard_713c1c15f492d76917685608680c4364.jpg" loading="lazy" alt="Jerry Tulassan" width="25" height="25"> </td> <td width=""> </td> <!--nom prenom--> <td align="left"> <img src="https://tracker.egora.fr/custloads/278893944/md_2683349.png" width="100%" style="display:block; font-family: sans-serif; display: block;" class="logo_CP" /> </td> <!--réponse--> <td align="left"> <p style="margin:0; font-weight:600;font-size:12px;text-align: center;text-transform: uppercase;color:#71b67b;font-family:'Montserrat', sans-serif;">Oui</p> </td> <td width="8"></td> </tr> </table> </td> </tr> <!--Argument text--> <tr> <td colspan="10"> <table width="97%" align="center" border="0" bgcolor="#fff" cellpadding="0" cellspacing="0"> <tr><td height="8"></td></tr> <tr> <td width="10"></td> <td> <a style="text-decoration:none !important;color:#797575;" data-url="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path" href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path#argument_2387668?" target="_blank"> <p style="margin:0;font-family:'Montserrat', sans-serif;font-size:12px;line-height:20px;">la médecine grâce à ChatGPT est à la portée d’un analphabète qui peux dicter sa question ou photographier le patient et écouter la réponse. Donner l... <a style="text-decoration:none !important; font-weight:bold;color:#797575;" data-url="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path" href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/espace-debat/debat/apres-l-angine-et-la-cystite-faut-il-autoriser-les-pharmaciens-a-prendre-en-charge-davantage-de-path#argument_2387668?" target="_blank">Lire plus </a> </p> </a> </td> <td width="8"></td> </tr> <tr><td height="8"></td></tr> </table> </td> </tr> </table> </td> </tr> </table> </td> </tr> <tr><td height="20"></td></tr> </table> </td> </tr> </div> <div class="field__item"> <!-- Placement de l'image --> <!-- Couleur de fond --> <!-- Quand il n'y a pas de code couleur --> <!-- TU CONSTRUIS TON TABLE AVEC LES VALEUR CI-DESSOUS --> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/etudiants/etudes-de-medecine/mg-france-redoute-lechec-de-la-4e-annee-de-medecine-generale-la?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;"> <table stycellspacing="0" cellpadding="0" bgcolor="#F5F6F8" class="inline_article" border="0" align="center" width="95%" style="width:95%; border-radius: 5px;"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center"> <table cellspacing="0" cellpadding="0" border="0" width="90%" style="width:90%" align="left"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/etudiants/etudes-de-medecine/mg-france-redoute-lechec-de-la-4e-annee-de-medecine-generale-la?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> MG France redoute "l'échec" de la 4e année de médecine générale : "La logique hospitalo-universitaire a prévalu" </a> </p> </td> </tr> </table> </td> <td class="inline_article" align="center" width="22%" style="width:22%; padding: 0px 0px 0px 0px;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/etudiants/etudes-de-medecine/mg-france-redoute-lechec-de-la-4e-annee-de-medecine-generale-la?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank"><img src="https://www.egora.fr/sites/default/files/styles/newsletter_article_avec_image/public/2025-05/alerte-attention.jpeg?itok=AlTdktDL" width="100%" style="width:100%; max-width:600; display:block; font-family: sans-serif; display: block;" class="logo_CP" /></a> </td> <td width="20"></td> </tr> <tr> <td height="10" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center" colspan="2"> <table cellspacing="0" cellpadding="0" border="0" width="100%" align="left"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; color:#6E6E6D; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/etudiants/etudes-de-medecine/mg-france-redoute-lechec-de-la-4e-annee-de-medecine-generale-la?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#6E6E6D; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> Alors que les textes encadrant la quatrième année d'internat de médecine générale doivent être publiés avant l'été, MG France estime que le processus de mise en œuvre de cette réforme est "dans l'impasse". Le syndicat appelle les pouvoirs publics à… </a> </p> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/etudiants/etudes-de-medecine/mg-france-redoute-lechec-de-la-4e-annee-de-medecine-generale-la?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="color:#DC344F; margin: 0;font-size: 12px !important;font-weight: bold;line-height: 24px; font-family:Arial; text-decoration: underline !important;">LIRE [...]</a> </td> </tr> </table> </td> <td width="20"></td> </tr> <tr> <td height="20" colspan="3"></td> </tr> </table> </a> </td> </tr> </div> <div class="field__item"> <!-- Placement de l'image --> <!-- Couleur de fond --> <!-- Quand il n'y a pas de code couleur --> <!-- TU CONSTRUIS TON TABLE AVEC LES VALEUR CI-DESSOUS --> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/actus-medicales/cancers-metastatiques-une-nouvelle-classe-therapeutique-prometteuse?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;"> <table stycellspacing="0" cellpadding="0" bgcolor="#F5F6F8" class="inline_article" border="0" align="center" width="95%" style="width:95%; border-radius: 5px;"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center" width="22%" style="width:22%; padding: 0px 0px 0px 0px;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/actus-medicales/cancers-metastatiques-une-nouvelle-classe-therapeutique-prometteuse?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank"><img src="https://www.egora.fr/sites/default/files/styles/newsletter_article_avec_image/public/2025-02/%C3%A9quipe%20-%20recherche.jpeg?itok=HD3ona2X" width="100%" style="width:100%; max-width:600; display:block; font-family: sans-serif; display: block;" class="logo_CP" /></a> </td> <td class="inline_article" align="center"> <table cellspacing="0" cellpadding="0" border="0" width="90%" style="width:90%" align="center"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/actus-medicales/cancers-metastatiques-une-nouvelle-classe-therapeutique-prometteuse?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> Cancers métastatiques : une nouvelle classe thérapeutique prometteuse </a> </p> </td> </tr> </table> </td> <td width="20"></td> </tr> <tr> <td height="10" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center" colspan="2"> <table cellspacing="0" cellpadding="0" border="0" width="100%" align="left"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; color:#6E6E6D; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/actus-medicales/cancers-metastatiques-une-nouvelle-classe-therapeutique-prometteuse?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#6E6E6D; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> Une équipe de chercheurs français a réalisé une avancée majeure dans la recherche contre les cancers métastatiques. </a> </p> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/actus-medicales/cancers-metastatiques-une-nouvelle-classe-therapeutique-prometteuse?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="color:#DC344F; margin: 0;font-size: 12px !important;font-weight: bold;line-height: 24px; font-family:Arial; text-decoration: underline !important;">LIRE [...]</a> </td> </tr> </table> </td> <td width="20"></td> </tr> <tr> <td height="20" colspan="3"></td> </tr> </table> </a> </td> </tr> </div> <div class="field__item"> <!-- Placement de l'image --> <!-- Couleur de fond --> <!-- Quand il n'y a pas de code couleur --> <!-- TU CONSTRUIS TON TABLE AVEC LES VALEUR CI-DESSOUS --> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/podcast/faits-diversjustice/un-legiste-raconte-lexamen-dune-victime-de-violences-conjugales-le?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;"> <table stycellspacing="0" cellpadding="0" bgcolor="#F5F6F8" class="inline_article" border="0" align="center" width="95%" style="width:95%; border-radius: 5px;"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center" width="22%" style="width:22%; padding: 0px 0px 0px 0px;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/podcast/faits-diversjustice/un-legiste-raconte-lexamen-dune-victime-de-violences-conjugales-le?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank"> <img src="https://www.egora.fr/sites/default/files/styles/newsletter_article_avec_image/public/newsletter/colonne/2025-05/Vignette%20l%C3%A9giste%20NL%205_1.png?itok=BAGkGFrk" width="100%" style="width:100%; max-width:600; display:block; font-family: sans-serif; display: block;" class="logo_CP" /> </a> </td> <td class="inline_article" align="center"> <table cellspacing="0" cellpadding="0" border="0" width="90%" style="width:90%" align="center"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/podcast/faits-diversjustice/un-legiste-raconte-lexamen-dune-victime-de-violences-conjugales-le?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> [PODCAST] Un légiste raconte l’examen d’une victime de violences conjugales : "Le corps était couvert d’ecchymoses et d’hématomes, de la tête aux pieds" </a> </p> </td> </tr> <tr> <td height="10" colspan="3"></td> </tr> <tr> <td class="inline_article" align="center" colspan="2"> <table cellspacing="0" cellpadding="0" border="0" width="100%" align="left"> <tr> <td class="inline" align="left"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/podcast/faits-diversjustice/un-legiste-raconte-lexamen-dune-victime-de-violences-conjugales-le?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="color:#DC344F; margin: 0;font-size: 12px !important;text-transform:uppercase;font-weight: bold;line-height: 24px; font-family:Arial; text-decoration: underline !important;">Écouter</a> </td> </tr> </table> </td> </tr> </table> </td> <td width="20"></td> </tr> <tr> <td height="20" colspan="3"></td> </tr> </table> </a> </td> </tr> </div> <div class="field__item"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td colspan="3"> <table stycellspacing="0" cellpadding="0" border="0" bgcolor="#F5F6F8" align="center" width="95%" style="border-radius: 5px;width: 95%;"> <tr> <td height="5" colspan="3"></td> </tr> <tr> <td align="center" width="100%"> <p style="font-family: Trebuchet MS; margin: 0;font-size: 20px;color: #1D1D1B;font-weight: 600;line-height: 22px;"> <!-- Titre section --> A la Une aujourd'hui <span style="color: #DC344F;font-size: 30px;">•</span> </p> </td> </tr> <tr> <td height="5" colspan="3"></td> </tr> </table> </td> </tr> </div> <div class="field__item"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/gestion-du-cabinet/juridique/medecin-radie-pour-violences-sur-ses-enfants-pourquoi-la-sanction-ete?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;"> <table stycellspacing="0" cellpadding="0" bgcolor="#F5F6F8" class="inline_article" border="0" align="center" width="95%" style="width: 95%; border-radius: 5px;"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center" width="50%" style="padding: 0px 0px 0px 0px;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/gestion-du-cabinet/juridique/medecin-radie-pour-violences-sur-ses-enfants-pourquoi-la-sanction-ete?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank"><img src="https://www.egora.fr/sites/default/files/styles/newsletter_a_la_une/public/2025-05/AdobeStock_1277944454%20m%C3%A9decin%20justice.jpg?itok=WBR5wh2U" width="100%" style="max-width:600; display:block; font-family: sans-serif; display: block; border-radius: 10px;" class="logo_CP" /></a> </td> <td class="inline_article" align="center" valign="top"> <table cellspacing="0" cellpadding="0" border="0" width="90%" style="width: 90%;" align="center"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; color:#DC344F; margin: 0;font-size: 11px;font-weight: 600;line-height: 24px; font-family:Arial;text-transform: uppercase;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/gestion-du-cabinet/juridique/medecin-radie-pour-violences-sur-ses-enfants-pourquoi-la-sanction-ete?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#DC344F; margin: 0;font-size: 11px;font-weight: 600;line-height: 24px; font-family:Arial;text-transform: uppercase;">Juridique</a> </p> <p style="text-decoration: none; color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/gestion-du-cabinet/juridique/medecin-radie-pour-violences-sur-ses-enfants-pourquoi-la-sanction-ete?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> Médecin radié pour violences sur ses enfants : pourquoi la sanction a été annulée </a> </p> </td> </tr> </table> </td> <td width="20"></td> </tr> <tr> <td height="10" colspan="3"></td> </tr> <tr> <td width="20"></td> <td class="inline_article" align="center" colspan="2"> <table cellspacing="0" cellpadding="0" border="0" width="100%" align="left"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; color:#6E6E6D; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/gestion-du-cabinet/juridique/medecin-radie-pour-violences-sur-ses-enfants-pourquoi-la-sanction-ete?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; color:#6E6E6D; margin: 0;font-size: 14px;font-weight: 400;line-height: 24px; font-family:Arial;"> Après avoir été radié du tableau de l’Ordre pour des faits de violences et de séquestration sur ses enfants, un médecin a vu cette sanction annulée par le Conseil d’Etat qui a jugé les faits graves mais commis hors du cadre professionnel et ayant… </a> </p> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/gestion-du-cabinet/juridique/medecin-radie-pour-violences-sur-ses-enfants-pourquoi-la-sanction-ete?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="color:#DC344F; margin: 0;font-size: 12px !important;font-weight: bold;line-height: 24px; font-family:Arial; text-transform: uppercase; text-decoration: underline !important;">LIRE [...]</a> </td> </tr> </table> </td> <td width="20"></td> </tr> <tr> <td height="20" colspan="3"></td> </tr> </table> </a> </td> </tr> </div> <div class="field__item"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td> <table stycellspacing="0" cellpadding="0" class="inline_article" border="0" align="center" width="95%" style="width: 95%;"> <tr> <!-- BLOC de GAUCHE --> <!-- TU CONSTRUIS TON TABLE AVEC LES VALEUR CI-DESSOUS --> <td width="49%" class="inline_article" bgcolor="#F5F6F8" style="vertical-align: top; background-color:#F5F6F8; border-radius: 5px;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/petites-annonces/medecin-generaliste?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;"> <table stycellspacing="0" cellpadding="0" class="inline_article" border="0" align="center"> <tr> <td width="100%" style="vertical-align: top;"> <table stycellspacing="0" cellpadding="0" class="inline_article" border="0" align="center"> <tr> <td class="inline_article" align="center" width="100%" style="padding: 0px 0px 0px 0px;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/petites-annonces/medecin-generaliste?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank"><img src="https://tracker.egora.fr/custloads/278893944/md_2688079.png" width="100%" style="display:block; font-family: sans-serif; display: block;" class="logo_CP" /></a> </td> </tr> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td class="inline_article" align="center"> <table cellspacing="0" cellpadding="0" border="0" width="90%" align="center" style="width: 90% !important;"> <tr> <td class="inline" align="left"> <p style="text-decoration: none; margin: 0;font-size: 11px;font-weight: 600;line-height: 24px; font-family:Arial;text-transform: uppercase;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/petites-annonces/medecin-generaliste?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none; margin: 0;font-size: 11px;font-weight: 600;line-height: 24px; font-family:Arial;text-transform: uppercase;"> <span style="color:#DC344F;"> <!-- type_annonce --> Petites annonces </span> <span style="color:#6E6E6D;"> • </span> <span style="color:#DC344F;"> <!-- type_offre --> Offre </span> <span style="color:#6E6E6D;"> • <!-- Région --> 19 Corrèze </span> </a> </p> <p style="text-decoration: none;color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/petites-annonces/medecin-generaliste?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;color:#1D1D1B; margin: 0;font-size: 17px;font-weight: 600;line-height: 24px; font-family:Arial;"> <!-- Titre du l'offre --> MEDECIN GENERALISTE </a> </p> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/petites-annonces/medecin-generaliste?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="color:#DC344F; margin: 0;font-size: 12px !important;font-weight: bold;line-height: 24px; font-family:Arial; text-decoration: underline !important;">LIRE L'ANNONCE</a> </td> </tr> </table> </td> </tr> <tr> <td height="20" colspan="3"></td> </tr> </table> </td> </tr> </table> </a> </td> <!-- FIN BLOC de GAUCHE --> <td class="inline_article" width="2%" ></td> <!-- BLOC de Droite --> <!-- Les 5 formations --> <!-- Titre du bloc --> <!-- TU CONSTRUIS TON TABLE AVEC LES VALEUR CI-DESSOUS --> <td width="49%" class="inline_article" bgcolor="#32D5C1" style="vertical-align: top; background-color:#32D5C1; border-radius: 5px;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/fmc?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;"> <table stycellspacing="0" cellpadding="0" class="inline_article" border="0" align="center"> <tr> <td width="100%" style="vertical-align: top;"> <table stycellspacing="0" cellpadding="0" class="inline_article" border="0" align="center"> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td class="inline_article" align="center"> <table cellspacing="0" cellpadding="0" border="0" width="90%" align="center" style="width: 90% !important;"> <tr> <td class="inline" align="left"> <p style="text-decoration: none;margin: 0;font-size: 20px;font-weight: 600;line-height: 20px; font-family:Arial;"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/fmc?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;margin: 0;font-size: 20px;font-weight: 600;line-height: 20px; font-family:Arial;"> <span style="color:#1D1D1B;">FMC :</span> <span style="color:#FFF;">10 points clés</span> </a> </p> </td> </tr> </table> </td> </tr> <tr> <td height="20" colspan="3"></td> </tr> <tr> <td class="inline_article" align="center"> <table cellspacing="0" cellpadding="0" border="0" width="90%" align="center" style="width: 90% !important;"> <tr> <td align="left" style="vertical-align: top;"> <img src="https://tracker.egora.fr/custloads/278893944/md_2674192.png" width="100%" style="display:block; font-family: sans-serif; display: block;" class="logo_CP" /> </td> <td width="5"></td> <td align="left"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/fmc?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;"> <p style="color:#FFF; margin: 0;font-size: 17px;font-weight: 600;line-height: 20px; font-family:Arial;"> <!-- nom de la rubrique --> Rhumatologie </p> <!-- nom de la formation --> <span style="color:#1D1D1B;font-size: 13px; font-weight: 600; line-height: 14px;font-family:Arial;">Goutte : modalités de traitement de la crise et au long cours</span> </a> </td> </tr> <tr> <td height="10" colspan="3"></td> </tr> <tr> <td align="left" style="vertical-align: top;"> <img src="https://tracker.egora.fr/custloads/278893944/md_2674192.png" width="100%" style="display:block; font-family: sans-serif; display: block;" class="logo_CP" /> </td> <td width="5"></td> <td align="left"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/fmc?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;"> <p style="color:#FFF; margin: 0;font-size: 17px;font-weight: 600;line-height: 20px; font-family:Arial;"> <!-- nom de la rubrique --> Pneumologie </p> <!-- nom de la formation --> <span style="color:#1D1D1B;font-size: 13px; font-weight: 600; line-height: 14px;font-family:Arial;">BPCO : la place centrale du médecin généraliste</span> </a> </td> </tr> <tr> <td height="10" colspan="3"></td> </tr> <tr> <td align="left" style="vertical-align: top;"> <img src="https://tracker.egora.fr/custloads/278893944/md_2674192.png" width="100%" style="display:block; font-family: sans-serif; display: block;" class="logo_CP" /> </td> <td width="5"></td> <td align="left"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/fmc?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="text-decoration: none;"> <p style="color:#FFF; margin: 0;font-size: 17px;font-weight: 600;line-height: 20px; font-family:Arial;"> <!-- nom de la rubrique --> Infectiologie </p> <!-- nom de la formation --> <span style="color:#1D1D1B;font-size: 13px; font-weight: 600; line-height: 14px;font-family:Arial;">Infections à VRS : plusieurs moyens de prévention</span> </a> </td> </tr> <tr> <td height="10" colspan="3"></td> </tr> </table> <tr> <td class="inline_article" align="center"> <table cellspacing="0" cellpadding="0" border="0" width="90%" align="center" style="width: 90% !important;"> <tr> <td align="left"> <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/medical/fmc?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En_Bref___lundi_12_mai_2025_20h30" target="_blank" style="color:#1D1D1B; margin: 0;font-size: 12px !important;font-weight: bold;line-height: 24px; font-family:Arial; text-decoration: underline !important;">VOIR PLUS</a> </td> </tr> </table> </td> </tr> </td> </tr> <tr> <td height="20" colspan="3"></td> </tr> </table> </td> </tr> </table> </a> </td> <!-- FIN BLOC de DROITE --> </tr> </table> </td> </tr> </div> </div> </table> <table stycellspacing="0" cellpadding="0" border="0" style="width: 100%;background: #FFFFFF;"> <tr> <td height="10" colspan="3"></td> </tr> </table> <!-- FOOTER --> <table cellspacing="0" cellpadding="0" border="0" align="center" bgcolor="#FFFFFF" class="container_header" width="600"> <tr> <td> <table stycellspacing="0" cellpadding="0" border="0" align="center" width="95%" style="width: 95%; padding: 0px 0px 0px 0px;"> <tr> <td height="30" colspan="3"></td> </tr> <tr> <td align="center" width="100%"> <a href="https://www.egora.fr" target="_blank"><img src="https://tracker.egora.fr/custloads/278893944/md_2670587.png" width="25%" style="max-width:100px; display:block; font-family: sans-serif; display: block;" class="logo_CP" /></a> </td> </tr> <tr> <td height="30" colspan="3"></td> </tr> </table> <table cellspacing="0" cellpadding="0" border="0" align="center" width="80%" style="width: 80%; padding: 0px 0;"> <tbody> <tr> <td height="0" colspan="7"></td> </tr> <tr> <td class="inline" valign="top" align="center" style="width: 20%;"> <a href="https://bsky.app/profile/egora.fr" target="_blank"><img style="width: 25%;" src="https://tracker.egora.fr/custloads/278893944/md_2717289.png" /></a> </td> <td class="inline" valign="top" align="center" style="width: 20%;"> <a href="https://www.instagram.com/egoranews/?hl=fr" target="_blank"><img style="width: 25%;" src="https://tracker.egora.fr/custloads/278893944/md_2717291.png" /></a> </td> <td class="inline" valign="top" align="center" style="width: 20%;"> <a href="https://fr.linkedin.com/showcase/egora.fr" target="_blank"><img style="width: 25%;" src="https://tracker.egora.fr/custloads/278893944/md_2717292.png" /></a> </td> <td class="inline" valign="top" align="center" style="width: 20%;"> <a href="https://www.facebook.com/egorafr-130520827015604/" target="_blank"><img style="width: 25%;" src="https://tracker.egora.fr/custloads/278893944/md_2717290.png" /></a> </td> <td class="inline" valign="top" align="center" style="width: 20%;"> <a href="https://www.youtube.com/@Egora-u3q" target="_blank"><img style="width: 25%;" src="https://tracker.egora.fr/custloads/278893944/md_2717293.png" /></a> </td> </tr> <tr> <td height="0" colspan="7"></td> </tr> </tbody> </table> <table cellspacing="0" cellpadding="0" border="0" align="center" width="90%" style="width: 90%; padding: 0px 0;"> <tbody> <tr> <td height="30" colspan="3"></td> </tr> <tr> <td class="inline" valign="top" align="center"> <span style="font-family: Arial;font-size: 14px; line-height: 25px;text-align: center; color: #6E6E6D; font-weight: 400;"> Vous recevez cet e-mail car vous avez accepté de recevoir des messages d'egora.fr. Le site <a href="https://www.egora.fr/" style="color: #6E6E6D;">www.egora.fr</a> est édité par la société Global Média Santé. SAS au capital de 4 289 852 € | RCS Nanterre B422 422 063 Tour Voltaire, 1 place des Degrés | CS 80235 Puteaux, 92059 Paris la Défense CEDEX <br /> Pour ne plus recevoir cette newsletter d'egora.fr, <a href="https://www.egora.fr/AutoConnect-MedOK?SiteID=61771f18-918c-45e8-b3c7-3ab1c6ddcc16&encrypted_id=$Autoconnect Egora$&ReturnUrl=https://www.egora.fr/inscription-aux-newsletters?utm_source=Newsletter&utm_medium=gms_egora&utm_campaign=En%20Bref%20-%20lundi%2012%20mai%202025%2020h30" style="color: #DC344F; font-weight:bold; text-decoration:underline;">modifiez vos préférences ici</a> </span> </td> </tr> <tr> <td height="30"></td> </tr> <tr> <td class="inline" valign="top" align="center"> <span style="font-family: Arial;font-size: 14px; line-height: 20px;text-align: center; color: #6E6E6D; font-weight: 400;">© EGORA 2025</span> </td> </tr> <tr> <td height="30"></td> </tr> </tbody> </table> </td> </tr> </table> </td> </tr> </table> </body> </html>